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UV radiation targets the skin and is a primary cause of
skin cancer (both melanoma and nonmelanoma skin
cancer). Exposure to UV radiation also suppresses the
immune response, and UV-induced immune suppres-
sion is a major risk factor for skin cancer induction.
The efforts of dermatologists and cancer biologists to
understand how UV radiation exposure suppresses
the immune response and contributes to skin cancer
induction led to the development of the subdiscipline
we call photoimmunology. Advances in photoimmu-
nology have generally paralleled advances in immu-
nology. However, there are a number of examples in
which investigations into the mechanisms underlying
UV-induced immune suppression reshaped our
understanding of basic immunological concepts.
Unconventional immune regulatory roles for Langer-
hans cells, mast cells, and natural killer T (NKT) cells,
as well as the immune-suppressive function of lipid
mediators of inflammation and alarmins, are just some
examples of how advances in immunodermatology
have altered our understanding of basic immunology.
In this anniversary issue celebrating 75 years of cuta-
neous science, we provide examples of how concepts
that grew out of efforts by immunologists and
dermatologists to understand immune regulation by
UV radiation affected immunology in general.
Journal of Investigative Dermatology (2012) 132, 896–905; doi:10.1038/
jid.2011.405; published online 15 December 2011
INTRODUCTION
Photoimmunology is defined as the study of the effects of
nonionizing radiation on the immune system. It grew from
experiments designed to understand the mechanism(s) under-
lying UVB radiation (290–320nm)-induced skin carcinogenesis.
In 1974, Kripke reported that skin cancers that arose in
UV-irradiated mice could not be successfully transplanted
into normal age- and sex-matched syngeneic recipient mice.
The tumors only grew progressively when they were
transplanted into immune-compromised recipients (Kripke,
1974). This finding indicated that the skin tumors induced
following cutaneous UV irradiation were highly antigenic,
and suppressing the host’s immune system was required to
allow the antigenic tumors to grow progressively in the
recipient. Left unanswered was the question of how these
tumors initially developed in the immune-competent UV-
irradiated host. Subsequent studies showed that in addition to
being carcinogenic, UV exposure induced immune suppres-
sion (Fisher and Kripke, 1977) in part by activating a special
class of immune regulatory cells, known in the 1970s as
suppressor T cells (Fisher and Kripke, 1982), but now known
as T regulatory cells (Schwarz, 2008).
Another early observation that confirmed that UV radia-
tion modulates immune function was provided by the
realization that cutaneous UV exposure affects antigen-
presenting cell function (Greene et al., 1979). UV exposure
destroys the dendritic cell network of Langerhans cells in the
skin (Streilein et al., 1980). Hapten sensitization through
UV-irradiated sites not only fails to induce contact hypersen-
sitivity (CHS), but also induces immune tolerance (Toews
et al., 1980), in part through the induction of T regulatory
cells (Elmets et al., 1983). These findings provided the early
foundation for the discipline we now call photoimmunology.
In this anniversary issue, celebrating 75 years of cutaneous
science, we will provide examples of how concepts that grew
out of efforts by immunologists and dermatologists to
understand skin carcinogenesis eventually affected immunol-
ogy in general.
IMPACT OF PHOTOIMMUNOLOGY ON IMMUNOLOGY
Because the immune suppression induced by UV exposure
is a major risk factor for skin cancer induction (Yoshikawa
et al., 1990), many investigators have set out to determine the
mechanisms involved. Photoimmunologists were not the first
to describe an immunosuppressive role for T cells, but unlike
mainstream immunologists, photoimmunologists never aban-
doned the concept that T cells suppressed cutaneous immune
reactions (i.e., contact- and delayed-type hypersensitivity)
and facilitated the growth of sunlight-induced skin cancers
(see ‘‘Regulatory T Cells-Banned Cells for Decades’’ in this
issue for more details). On the other hand, some of the very
first reports that Langerhans cells have immune regulatory
function came from cutaneous biologists studying the effect
of UV radiation on antigen presentation (Streilein et al., 1980;
Toews et al., 1980). Although most textbooks define
REVIEW
896 Journal of Investigative Dermatology (2012), Volume 132 & 2012 The Society for Investigative Dermatology
Received 23 June 2011; revised 25 July 2011; accepted 27 July 2011;
published online 15 December 2011
1Department of Immunology, University of Texas MD Anderson Cancer
Center, Houston, Texas, USA and 2Department of Infectious Diseases and
Immunology, Sydney Medical School, University of Sydney, Sydney,
New South Wales, Australia
Correspondence: Stephen E. Ullrich, Department of Immunology, University
of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston,
Texas 77030, USA. E-mail: sullrich@mdanderson.org
Abbreviations: CGRP, calcitonin gene–related peptide; CHS, contact
hypersensitivity; CPD, cyclobutane pyrimidine dimer; DTR, dipthteria toxin
receptor; NKT, natural killer T; PAF, platelet-activating factor; UCA, urocanic
acid; UV-B-reg, UV-activated B regulatory cell
Langerhans cells as the antigen-presenting cells in the
skin responsible for immune surveillance, recent reports
have suggested that dermal dendritic cells may have a
more prominent role as the cutaneous antigen-presenting
cells (Fukunaga et al., 2008; Stein et al., 2011), and that
Langerhans cells may be more important for the activation
of regulatory cells (Fukunaga et al., 2010; see ‘‘Changing
Views of the Role of Langerhans Cells’’ in this issue for
more details). Regardless, a role for Langerhans cells in
immune regulation was pioneered by photoimmunologists
30 years ago.
Mast cells regulate adaptive immune reactions
Mast cells are bone marrow–derived cells that circulate in
the blood as immature progenitors. They migrate into
peripheral tissues where they differentiate into mature,
long-lived mast cells. Conventional wisdom suggests that
tissue-resident mast cells primarily serve as effector cells in
IgE-mediated allergic reactions, in part through the release of
preformed mediators stored in the cytoplasmic granules of
the cell. However, immunologists now realize that mast
cells regulate adaptive immune responses via the release of
cytokines and other immune-modulatory factors (Galli et al.,
2008). Some of the first reports indicating that mast cells
suppress adaptive immune reactions were published by those
studying the mechanisms by which UV exposure suppresses
CHS. Niizeki et al. (1997) found that UV radiation induced
the release of calcitonin gene–related peptide (CGRP) from
cutaneous nerve endings, which ultimately suppressed the
induction of CHS. When determining the mechanism
involved, they found that CGRP induced mast cells to release
tumor necrosis factor-a and concluded that ‘‘CGRP or UV
radiation impairs CHS via an effect on mast cells.’’ Hart et al.
(1998) provided formal proof for the role of mast cells in
UV-induced immune suppression. These studies used c-Kit
mutant, mast cell–deficient Wf/Wf mice. These mice are
immune competent and are capable of generating a vigorous
CHS reaction when a contact allergen is applied to the
skin. However, when the mast cell–deficient mice were first
exposed to UV radiation and then sensitized with hapten,
no immune suppression was noted. Susceptibility to the
immunosuppressive effects of UV radiation was restored
when the mice were first reconstituted with bone marrow–-
derived mast cells and then UV irradiated (Hart et al., 1998).
These results have been confirmed by others (Alard et al.,
1999, 2001). In addition, mast cells have a critical role
in suppressing secondary immune reactions by UVA
(320–400nm) radiation (Ullrich et al., 2007). Mast cell
density in non-sun-exposed human skin correlates positively
with the risk of melanoma (Grimbaldeston et al., 2004) and
basal cell carcinoma (Grimbaldeston et al., 2000, 2003),
suggesting that the immune regulatory property of mast cells
may contribute to skin cancer induction.
The skin absorbs UVB, yet UV exposure induces system-
wide immune suppression. How the immune suppressive
signal is transmitted from the skin to the lymph nodes is not
entirely clear, but migrating mast cells have a role. Following
UV exposure, mast cell density in the skin quickly increases
and peaks 6 hours after UV exposure (Figure 1). This was not
too surprising because mast cell progenitors are recruited to
areas of inflammation, such as UV-irradiated skin. What was
surprising was that within 24 hours the numbers of mast cells
in the skin-draining lymph nodes, but not distant lymph
nodes (i.e., popliteal), were significantly increased. This
suggested that the mast cells were migrating from the skin to
the draining lymph node. To determine that this was the case,
skin from green fluorescent protein (GFP)–positive mice was
grafted onto the backs of mast cell–deficient mice. The
animals were then exposed to UV radiation. The appearance
of green fluorescent protein–positive mast cells in the lymph
nodes of UV-irradiated mast cell–deficient mice, but not in
the nodes of skin-grafted unirradiated mice, confirmed the
hypothesis that UV irradiation triggers the migration of mast
cells from the skin to the lymph nodes (Byrne et al., 2008).
This UV-induced mast cell migration was dependent on the
CXCR4–CXCL12 chemokine pathway, as CXCL12 was
significantly upregulated in draining lymph nodes (Figure 2)
and CXCR4þ mast cells were blocked from migrating in vivo
in the presence of the CXCR4 antagonist, AMD3100. This
had immune implications because blocking mast cell
migration in this way also prevented UV-induced immuno-
suppression (Byrne et al., 2008).
In addition to cell-mediated immune reactions, UV
irradiation suppresses antibody formation (Spellman et al.,
1984; Brown et al., 1995; El-Ghorr et al., 1998). Mast cells
have a prominent role in suppressing antibody formation
in vivo. Wild-type mice were first exposed to UV radiation
and 3 days later immunized with a T-dependent antigen
(dinitrophenyl-keyhole limpet hemocyanin). Germinal center
formation, antibody secretion, and T follicular helper cell
generation were all suppressed by prior UV exposure
(Figure 2). Injecting the UV-irradiated mice with cromolyn,
a well-known inhibitor of mast cell function, blocked the
suppression of antibody formation. Moreover, when mast
cell–deficient mice were UV irradiated and immunized with
dinitrophenyl-keyhole limpet hemocyanin, antibody forma-
tion, germinal center formation, and T follicular helper cell
generation were not different from what was seen in
unirradiated controls. We were able to restore UV-induced
suppression of antibody formation by reconstituting mast
cell–deficient mice with mast cells derived from the bone
marrow of wild-type mice. Reconstituting the mast cell–defi-
cient mice with mast cells derived from IL-10-deficient
mice failed to restore the ability of UV radiation to suppress
antibody formation, indicating the importance of mast
cell–derived IL-10 in UV-induced immune suppression.
These findings are among the first to demonstrate that mast
cells and mast cell–derived IL-10 inhibit antibody formation
by suppressing T follicular helper function (Chacon-Salinas
et al., 2011).
Experiments demonstrating an immune regulatory role for
mast cells depend heavily on the use of mast cell–deficient
mice (Grimbaldeston et al., 2005). Immune function and
inflammation are often enhanced in mast cell–deficient mice
and restored to normal when bone marrow–derived mast cells
are transplanted into the mice (see as an example Li et al.,
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2011). These findings indicate an immune regulatory role for
mast cells. Data presented in a recent paper, using new
strains of mast cell–deficient mice, are challenging the
concept that mast cells have immunosuppressive potential
(Dudeck et al., 2011). Mice were genetically engineered with
the mast cell protease 5 promoter driving the expression of a
simian dipthteria toxin receptor (Mcpt5-DTR). Because mice
do not normally express the DTR, using a mast cell–specific
promoter to drive expression of the DTR results in mice in
which the DTR is only expressed by mast cells. Injecting
these mice with dipthteria toxin results in a selective
depletion of mast cells. Unlike the situation found in Kit
mutant mice, where CHS was enhanced in the absence of
mast cells (Grimbaldeston et al., 2007), when Mcpt5-DTR
was first injected with dipthteria toxin, and then sensitized
with hapten, a depressed CHS reaction (B50% of the
response found in the controls) was observed. Similar results
were obtained in constitutively mast cell–deficient mice (the
mast cells commit suicide in mice in which both the toxin
receptor and the toxin-producing genes are expressed only in
mast cells). Because these results challenge the paradigm that
mast cells are immune reagulatory, it will be important to use
these mice in models of UV-induced immune suppression to
validate or challenge previous results.
Solar-activated suppressor B cells
Although they do not receive as much attention as T
regulatory cells, B cells can also suppress the immune
response, primarily by secreting immune-regulatory cyto-
kines, such as IL-10. Following cutaneous UV irradiation, the
size and cellularity of the lymph nodes that drain the skin
increase significantly. Byrne and Halliday (2005) studied the
identity and function of the cells in the draining lymph nodes
to gain a better understanding of the mechanisms driving
immune suppression. They observed increased numbers of
dendritic cells and B cells in the draining lymph nodes of UV-
irradiated mice. The migration of dendritic cells to the lymph
node was not too surprising, as UV-induced migration of
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Figure 1. Cutaneous photoimmunological events. A number of early/
immediate immune-modulating events (middle panel) occur in the skin
following exposure to UV radiation, including: (A) isomerization of
trans-urocanic acid (UCA) to the immune-suppressive cis-UCA isoform
(De Fabo and Noonan, 1983; Gibbs et al., 2008); (B) production of the
biologically active lipid mediator, platelet-activating factor (PAF; Alappatt
et al., 2000; Travers et al., 2010), which contributes to skin cancer
development (Sreevidya et al., 2008) by suppressing both adaptive immunity
(Walterscheid et al., 2002) and DNA repair (Sreevidya et al., 2010); and
(C) recruitment of immune-modulating mast cells into the dermis peaking at
6 hours after UV irradiation (Byrne et al., 2008). These early events precipitate
a number of later photoimmunological events (bottom panel), including:
(D) the production of immune-modulating IL-33 in keratinocytes and dermal
fibroblasts (Byrne et al., 2011); and (E) the migration of epidermal Langerhans
cells (Streilein et al., 1980), dermal dendritic cells (dDCs; Fukunaga et al.,
2010); and (F) CXCR4þ dermal mast cells to the local draining lymph nodes
(DLNs) (Byrne et al., 2008). (G) Activation of complement components in the
skin (including those associated with the alternative pathway; factor B and
properdin; Stapelberg et al., 2009) also contributes to UV-induced immune
suppression (Hammerberg et al., 1998; Yoshida et al., 1998).
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Langerhans cells is a well-described phenomenon. In
addition, they noted no alteration in lymph node dendritic
cell phenotype, and activation and function were not
affected. Furthermore, injecting hapten-conjugated dendritic
cells from normal or UV-irradiated mice into recipient
animals activated CHS. This was somewhat surprising
because conventional wisdom suggests that UV irradiation
imparts a defect in draining lymph node dendritic cell
function (Okamoto and Kripke, 1987), although it must be
kept in mind that others have reported that dendritic cell
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Figure 2. Photoimmunological events occurring in skin-draining lymph nodes. Immunosuppressive signals generated in the skin are transmitted by
Langerhans cells (LCs) and mast cells to the local skin-draining lymph nodes to regulate both humoral and cell-mediated immune responses.
(A, left panel) In response to immunization with protein antigens, B cells are activated by IL-21-expressing T follicular helper (Tfh) cells in germinal
centers to produce IgG1 antibodies. (A, right panel) Mast cells that have migrated from UV-irradiated skin suppress this humoral arm of adaptive
immunity by homing to B-cell areas and producing IL-10 (Chacon-Salinas et al., 2011). At the same time, (B) CD207 (Langerin)þCD1dþ epidermal
LCs migrate from UV-irradiated skin to the T-cell zones where they activate IL-4–producing immunosuppressive natural killer T (NKT) cells (Fukunaga et al.,
2010). Meanwhile, (C) UV-induced upregulation of CXCL12 (SDF1a) in B-cell follicles attracts CXCR4þ dermal mast cells to the draining lymph nodes
(Byrne et al., 2008). It is at this time that IL-10-producing UV-activated B regulatory cells, or ‘‘UV-B-regs,’’ are induced (Byrne and Halliday, 2005) via a
platelet-activating factor (PAF)- and serotonin-dependent mechanism (Matsumura et al., 2006). BCR, B cell receptor; FDC, follicular dendritic cell;
MHC II, major histocompatibility complex II.
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function in the lymph nodes of UV-irradiated mice was
normal (Lappin et al., 1996; Gorman et al., 2005). On the
other hand, the B cells found in the lymph nodes expressed
an activated phenotype (i.e., increased major histocompat-
ibility complex class II expression, B220 upregulation, and
increased IL-10 secretion; Figure 2). When the B cells from
UV-irradiated mice were mixed with hapten-conjugated
dendritic cells isolated from either normal or UV-irradiated
mice and injected into recipient mice, the subsequent CHS
reaction was significantly suppressed (Byrne and Halliday,
2005). These data indicate that lymph nodes draining UV-
irradiated skin contain a population of B cells that can
suppress dendritic cell function. The authors suggest that B
cell–derived IL-10 is involved.
These findings were subsequently confirmed by Matsu-
mura et al. (2006). Transferring lymph node cells from the
UV-irradiated mice into normal recipients suppressed the
induction of CHS in the recipient mice and induced long-
lasting immune tolerance. The FITC-positive cells that
transferred immune suppression and induced tolerance
were CD19þ , B220þ , B cells. Transferring cells from
FITC-immunized B cell–deficient mice failed to induce
immune suppression or induce tolerance. Similarly, no
immune suppression resulted when lymph node cells from
FITC-immunized IL-10–deficient mice were transferred,
indicating that IL-10-producing B cells were involved. In
the gut, chronic inflammation induces IL-10-secreting im-
mune-suppressive B cells (Mizoguchi et al., 2002). It is now
clear that UV-induced inflammation also has a role in the
induction of immune-suppressive B cells. Two important
UV-induced mediators of inflammation found in the skin
are platelet-activating factor (PAF) (Marathe et al., 2005)
and serotonin (Slominski et al., 2005). By using a combina-
tion of selective PAF and serotonin receptor antagonists, and
receptor-deficient mice, Matsumura et al. (2006) demon-
strated that both PAF and serotonin were involved in the
generation of UV-activated B regulatory cells, or ‘‘UV-B-
regs.’’ B cells have a key role in skin cancer promotion (de
Visser et al., 2005), and activation of UV-B-regs is likely to be
an important contributor to the ability of UV radiation to
induce skin cancer, as blocking both the PAF and serotonin
pathways not only inhibits the generation of UV-B-regs, but
also protects mice from developing UV-induced skin cancer
(Sreevidya et al., 2008).
An unconventional role for an unconventional T cell
A unique class of T cells, known as natural killer T (NKT), was
first described in the late 1980s (reviewed by Vicari and
Zlotnik, 1996). They were called NKT cells because this
unconventional T-cell subset expresses surface markers
normally found on T cells (CD4, ab T-cell antigen receptor),
as well as receptors normally expressed on natural killer cells
(NK1.1, DX5). Unlike conventional T cells, NKT cells do not
recognize peptide antigens presented by major histocompat-
ibility complex, but rather recognize lipid antigens presented
by CD1. Although it is now understood that NKT cells can
either enhance or suppress immune reactions, initially it was
believed that NKT cells, by virtue of their ability to rapidly
secrete large amounts of IFN-g upon activation, only
enhanced immune reactions (Kronenberg and Gapin,
2002). One of the first reports that NKT cells can have
suppressive activity came from a study investigating the
mechanisms responsible for UV-induced immune suppres-
sion. As shown previously, transferring T cells from UV-
irradiated mice exposed to a chronic subcarcinogenic dose of
UV radiation into recipient mice suppressed the immune
response of the recipient mouse and allowed for the
progressive growth of highly antigenic UV-induced skin
cancers (Fisher and Kripke, 1978). Moodycliffe et al. (2000)
found that transferring NKT cells (CD4þ , DX5þ ) from the
spleens of mice exposed to a chronic subcarcinogenic dose of
UV radiation to normal recipients suppressed the immune
response and allowed for the progressive growth of the skin
cancers. In addition, when NKT cells were transferred from
mice that were exposed to UV radiation and then immunized
with Candida albicans, delayed-type hypersensitivity in the
recipient mice was suppressed (Moodycliffe et al., 2000).
Failure to induce immune-regulatory NKT cells when CD1-
deficient mice were UV irradiated provided additional
evidence indicating that NKT cells were responsible.
Langerhans cells that migrate from the skin of UV-
irradiated mice to the draining lymph nodes are essential
for activating these NKT cells in vivo (Fukunaga et al., 2010;
Figures 1 and 2). The induction of CHS was significantly
depressed when the mice received Langerhans cells
(CD207þ , Ep-Camþ , CD24aþ , CD103) isolated from
the lymph nodes of UV-irradiated mice. This was in direct
contrast to what was found when hapten-conjugated
Langerhans cells from normal mice were used or when
hapten-conjugated dermal dendritic cells isolated from UV-
irradiated mice were injected into normal recipients. Micro-
scopic examination of the draining lymph nodes indicated
that the Langerhans cells migrated to the T-cell area of the
node, and were in close approximation to NKT cells
(Figure 2). No immune suppression was observed when
hapten-conjugated Langerhans cells from UV-irradiated mice
were injected into NKT-deficient animals (CD1/ or Ja18/
mice). NKT cells isolated from the lymph nodes secreted IL-4,
and anti-IL-4 monoclonal antibody blocked immune suppres-
sion. These data indicate that Langerhans cells transmit an
immune-suppressive signal from the skin to lymph nodes,
where they activate NKT cells to secrete immune-regulatory
cytokines.
Cutaneous mediators of immune suppression
As mentioned above, UVB radiation, which is absorbed in
the skin, induces system-wide immune regulation. We know
that migrating mast cells and Langerhans cells have an
important role in activating systemic immune suppression,
but a great deal of attention has also been addressed in
determining the cutaneous signals that activate the process.
Keratinocytes are activated to release a wide variety of
immune-modulatory factors following UV irradiation (re-
viewed by Ullrich, 2005). In the course of these studies, the
investigators have often discovered novel immune-regulatory
processes (Figure 1).
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Cis-urocanic acid (cis-UCA)
Trans-UCA is found in the stratum corneum, and upon UV
radiation exposure, it isomerizes to the cis-isoform (Anglin
et al., 1961). Cis-UCA has potent immune-suppressive
properties (as initially demonstrated by De Fabo and Noonan,
1983 and recently reviewed by Gibbs et al., 2008). Cis-UCA
mediates immune suppression by binding to the serotonin
(5HT-2A) receptor (Walterscheid et al., 2006; Shen and Ji,
2009). A monoclonal antibody to cis-UCA significantly
reduced the numbers of skin cancers induced in UV-
irradiated mice (Beissert et al., 2001). It is interesting to note
that Hart et al. (2002) demonstrated that cis-UCA activates
nerve endings in the skin to release neuropeptides that
activate mast cells; therefore, cis-UCA production may
activate mast cell migration.
Some recent findings, however, may cause a reevaluation
of the role of cis-UCA in cancer induction. Laihia et al. (2010)
found that applying cis-UCA to melanoma cells in culture, at
pH 6.5, promotes intracellular acidification that results in
apoptotic cell death. In addition, injecting cis-UCA into
melanoma tumor xenografts suppressed tumor growth
in vivo, demonstrating a direct anticancer effect for
cis-UCA (Laihia et al., 2010). The photoprotective role of
cis-UCA may also have a role. UCA is produced by histidase.
The stratum corneum of mice with a mutation in the histidase
gene is deficient in UCA, and these mice demonstrate a
decreased ability to absorb UVB radiation. When the dorsal
skin of the UCA-deficient mice was exposed to UVB
radiation, pyrimidine dimer formation and apoptosis was
increased. Applying cis-UCA to the skin of the UCA-deficient
mice reduced UVB-induced pyrimidine dimer formation
(Barresi et al., 2010). These findings indicate that cis-UCA
modulates UV-induced DNA damage in the skin and kills
melanoma cells.
Inflammatory mediators with immune-suppressive properties
that unexpectedly affect DNA repair
Immunologists are well aware that cytokines and chemokines
can activate and regulate the immune response. Perhaps not
as well appreciated are the immune-modulatory functions of
biologically active lipid mediators, such as PAF. They have
important roles in multiple organ systems (i.e., gastrointest-
inal, cardiovascular, reproductive, and pulmonary) as
regulators of inflammation, cell migration, differentiation,
and cell proliferation. The PAF receptor is found on platelets
and a wide variety of immune cells, including neutrophils,
macrophages, eosinophils, and mast cells, as well as T and B
cells (Shimizu, 2009). Acute skin damage caused by UV
radiation activates keratinocytes to secrete PAF (Alappatt
et al., 2000; Travers et al., 2010; Figure 1). Evidence
indicating that PAF mediates UV-induced immune suppres-
sion was presented by Walterscheid et al. (2002), who found
that selective PAF-receptor antagonists blocked UV-induced
IL-10 and prostaglandin E-2 transcription in vitro and immune
suppression in vivo. Moreover, injecting PAF into mice
mimicked the effect of UV radiation and activated immune
suppression. The failure to induce immune suppression in
UV-irradiated PAF receptor–deficient mice provided the
ultimate proof that PAF receptor binding is a critical step in
the immune-suppressive pathway (Wolf et al., 2006; Zhang
et al., 2008). PAF also has a role in UV-induced hyperalgesia
(Zhang et al., 2009), and has been reported to be an essential
factor in the generation of immune suppression observed
following the application of aromatic hydrocarbons (i.e., jet
fuel) to the skin (Ramos et al., 2004).
Using a microarray analysis, Travers et al. (2008) reported
that PAF augments UV-induced keratinocyte gene expres-
sion, suggesting a potential mechanism of action. Although
PAF is a well-known transcriptional activator, which is
consistent with its augmentation of gene expression, its
mechanism of action may be related to its ability to affect
DNA repair. When UV-irradiated hairless mice were injected
with either a PAF or a serotonin receptor antagonist, tumor
incidence and tumor progression were significantly sup-
pressed. In addition, the two drugs, when injected in
suboptimal dose, worked synergistically to suppress tumor
induction in that only 25% of irradiated mice developed a
skin cancer (Sreevidya et al., 2008). Presumably, blocking the
binding of PAF and cis-UCA to their receptors was blocking
the generation of UV-B-regs and the induction of immune
suppression, thus depressing skin cancer induction. How-
ever, a subsequent study by Sreevidya et al. (2010) indicated
that PAF and serotonin receptor antagonists have an
additional function in vivo: acceleration of DNA repair. The
investigators noted that treating UV-irradiated mice with PAF
or serotonin antagonists did not prevent cyclobutane
pyrimidine dimer (CPD) formation in the skin (a control to
ensure that the drugs were not sunscreens). However, they
observed that the repair of CPD was significantly accelerated
in mice injected with a PAF or a serotonin receptor
antagonist. Nucleotide excision repair was accelerated in
the skin of UV-irradiated PAF-injected or serotonin receptor
antagonist–injected mice; however, the drugs had no effect
on DNA repair in xeroderma pigmentosum–deficient animals,
which lack the genes required to carry out nucleotide
excision repair. The formation of reactive oxygen species
and 8-oxo-deoxyguanosine was also suppressed in the skin of
UV-irradiated receptor antagonist–injected mice. These data
indicate that inflammatory mediators such as PAF depress
DNA repair, which provides a mechanistic link between
inflammation, immune suppression, and cancer induction.
These findings were reminiscent of the data regarding the
dual effects of the classic immune stimulatory cytokine, IL-
12. UV-induced immune suppression, the induction of T
regulatory cells, and the induction of immune tolerance are
all reversed by recombinant IL-12 (Schmitt et al., 1995;
Schwarz et al., 1996). Undoubtedly, the immune-promoting
effects of IL-12 are critical; however, as described by Schwarz
et al. (2002), IL-12 has dual effects. Treating UV-irradiated
keratinocytes with IL-12 inhibits UV-induced apoptosis.
UV-induced CPD formation and sunburn cell formation
was reduced by IL-12 treatment. No reversal of sunburn
cell formation was noted when IL-12 was injected into
UV-irradiated xeroderma pigmentosum–deficient mice, in-
dicating that IL-12 activated nucleotide excision repair.
Similarly, CPD formation induced by in vitro irradiation of
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human peripheral blood mononuclear cells was suppressed
by IL-12, but no suppression of CPD formation was observed
when peripheral blood mononuclear cells from xeroderma
pigmentosum patients were exposed to UV radiation and
treated with IL-12. The findings from these studies confirm
the important role that DNA damage and its repair has in UV-
induced immune suppression (Kripke et al., 1992). They also
highlight the novel and unexpected dual role that immune-
modulatory factors (IL-12, PAF, serotonin, and cis-UCA) have
on DNA repair.
As mentioned above, cis-UCA is immunosuppressive and
photoprotective. These findings at first glance appear to be
counterintuitive and raise the larger question of why UV
radiation, a common daily event, induces immune suppres-
sion. A number of possible explanations have been proposed.
UV-induced immune suppression may serve to prevent an
autoimmune reaction to neoantigens that may arise in the
skin following UV exposure (reviewed by Kripke, 1994).
Another point of view suggests that UV-induced immune
suppression is a transient side effect triggered by the attempt
to maintain genomic integrity (Ullrich, 2008). Following UV
exposure, the cell must either repair the damage or, if the
damage is too extensive, undergo apoptosis. To repair
DNA damage, the cell must arrest at the G2/M checkpoint.
UV-induced activation of mitogen-activated protein kinase
p38 is critical for the initiation of cell cycle arrest (Bulavin
et al., 2001). Activated mitogen-activated protein kinase
p38 promotes the activation of PLA2, the first enzymatic step
in the synthesis of PAF (Ishii and Shimizu, 2000). Activated
mitogen-activated protein kinase p38 also promotes IL-10
transcription (Ma et al., 2001). The photoprotective role of
UCA is consistent with the genomic integrity model, and
consistent with the idea that evolution permitted transient
immune suppression in exchange for a mechanism to pro-
mote genomic integrity following a common environmental
insult (sunlight exposure).
A cutaneous alarmin that uncharacteristically induces
immunosuppression
Alarmins are endogenous messengers that are released
following cellular damage and serve to activate innate and
adaptive immune reactions to deal with infection or tissue
damage. Some prominent examples are high-mobility group
box 1 proteins, heat-shock proteins, uric acid, IL-1a,
defensins, and cathelicidins (see ‘‘Antimicrobial Peptides’’
in this issue for more details). Alarmins are chemoattractants;
they induce the migration of antigen-presenting cells to sites
of damage. Alarmins activate antigen-presenting cells and
generally stimulate the immune response by enhancing
immune function (reviewed by Oppenheim and Yang, 2005).
A newly described alarmin is IL-33. In the gut, its
conventional function is to enhance the immune response
and attenuate sepsis and parasitic infection (Alves-Filho et al.,
2010; Neill et al., 2010). However, a recent report indicates
that keratinocyte-derived IL-33 depresses immune function
(Byrne et al., 2011). Exposing skin (either intact mouse or
human skin and murine or human keratinocyte cultures) to
UVB, but not UVA, radiation upregulates IL-33 expression
(Figure 1). Injecting mice with recombinant IL-33 suppresses
the induction of CHS, and treating UV-irradiated mice
with antibodies to IL-33 blocks UV-induced immune
suppression. An indirect mechanism appears to be involved.
Treating fibroblast cultures with PAF, but not cis-UCA,
induced IL-33 expression, indicating a role for PAF in alarmin
production. To the best of our knowledge, this is the first
report to show that alarmins can downregulate the immune
response.
Is complement an environmental sensor for UV radiation
damage?
A number of years ago, Hammerberg et al. (1998) observed
that immune suppression and immune tolerance was not
induced in complement (C3)-deficient mice. Subsequent
studies indicated that products of complement activation
are expressed in UV-irradiated human skin, and that binding
of the activated C3 fragment, iC3b, to its receptor (CD11b) on
monocytes results in increased IL-10 secretion with con-
comitant suppression in IL-12 secretion (Yoshida et al.,
1998). These results were somewhat surprising, but do fit in
with the known role of inflammation, and inflammatory
products, in UV-induced immune suppression. Recently, this
issue was revisited by Stapelberg et al. (2009), who were
interested in discerning the molecular triggers for UVA-
induced immune suppression. UVA radiation exposure is
immunosuppressive, but unlike UVB radiation, where the
dose–response curve for the induction of immune suppression
is linear, the dose–response curve for UVA radiation is bell
shaped in both mice (Byrne et al., 2002) and humans
(Matthews et al., 2010). Moreover, exposure to high doses of
UVA radiation given before an immunosuppressive dose of
UVB radiation is immunoprotective (Reeve et al., 1998). A
microarray analysis was performed using RNA isolated from
the skin of mice exposed to a relatively low (immunosup-
pressive) dose of UVA radiation. Only genes comprising the
alternative complement pathway (C3, complement factor B,
and properdin) were activated (Figure 1G). This pathway was
not activated by high-dose UVA or low-dose UVB radiation.
The observation that complement may serve as an environ-
mental sensor is novel, but whether other skin-damaging
agents activate complement to influence immunity remain to
be seen.
CONCLUSIONS
The UV radiation in sunlight is a major environmental
carcinogen, and because UV-induced immune suppression is
a major risk factor for skin cancer induction, dermatologists
and cancer immunologists have a long history of studying the
mechanisms involved. Advances in photoimmunology have
generally paralleled advances in immunology (i.e., important
role of antigen presentation, role of cytokines in regulating
the response, and critical role of regulatory cells in
dampening immune reactions). However, there are a number
of examples where investigations into the mechanisms
underlying UV-induced immune suppression have led to
new immunological insights. This review was not meant to be
all-inclusive (and we apologize to the many investigators
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whose work was not mentioned here because of space
limitations), but rather to show examples of how advances
made by photoimmunologists eventually became well
accepted in the mainstream immunological literature (for
readers who are interested in a more comprehensive
treatment of the subject, we suggest three recent reviews:
Norval and Halliday, 2011; Norval and Woods, 2011;
Ullrich, 2011). The idea that Langerhans cells, mast cells,
and NKT cells can also serve in an unconventional manner to
regulate the immune response is now well accepted in the
general immunological community; it had its first acceptance
in the photoimmunological community. The realization that
bioactive lipids can suppress the immune response, and the
understanding of the unique role of IL-12, cis-UCA, and PAF
in modulating DNA repair came from studies by investigators
whose focus on skin, sunlight, carcinogenesis, and immune
suppression equipped them to recognize unconventional
roles for conventional molecules. It appears that the same can
be said for IL-33—its role as a mediator for UV-induced
immune suppression is certainly outside the normal de-
scribed function of alarmins. None of this should be too
surprising. One constant of science is that once the
community thinks we really understand something, new
findings generally turn the existing dogma upside down.
What we have tried to do here is briefly list some examples of
advances made by cutaneous immunologists that have
helped to alter conventional immunological wisdom.
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